Recently, a study in a mouse model of liver fibrosis showed that tenofovir (TDF) treatment led to activated HSC apoptosis by downregulating the PI3K/Akt/mammalian target of the rapamycin (mTOR) signaling pathway, ultimately improving liver fibrosis [66]. The gene discussed is MTOR; the disease is Hepatic fibrosis.